Evaluation of disease-free survival as a predictor of overall survival and assessment of real-world burden of disease recurrence in resected early-stage non-small cell lung cancer.
West H, Hu X, Zhang S, Song Y, Chirovsky D, Gao C, Lerner A, Jiang A, Signorovitch J, Samkari A.
West H, et al. Among authors: lerner a.
J Manag Care Spec Pharm. 2023 Jul;29(7):749-757. doi: 10.18553/jmcp.2023.29.7.749.
J Manag Care Spec Pharm. 2023.
PMID: 37404067
Free PMC article.
Patients with postsurgery recurrence had a higher risk of death and incurred higher HCRU and health care costs than those without recurrence. ...Drs Zhang, Song, Gao, and Signorovitch, Mr Lerner, and Ms Jiang are employees of Analysis Group, Inc., a consultin …
Patients with postsurgery recurrence had a higher risk of death and incurred higher HCRU and health care costs than those without rec …